Access cutting-edge idiopathic pulmonary fibrosis treatment through this clinical trial at a research site in Philadelphia. Study-provided care at no cost to qualified participants.
Access idiopathic pulmonary fibrosis specialists in Philadelphia at no cost
This study follows strict safety protocols and ethical guidelines
All study-related idiopathic pulmonary fibrosis treatment provided free
The goal of this clinical trial is to learn about INS018\_055 in adults with Idiopathic Pulmonary Fibrosis (IPF). The primary objective is to evaluate the safety and tolerability of INS018\_055 orally administered for up to 12 weeks in adult subjects with IPF compared to placebo.
Sponsor: InSilico Medicine Hong Kong Limited
Check if you qualify for this idiopathic pulmonary fibrosis clinical trial in Philadelphia, PA
If you're searching for idiopathic pulmonary fibrosis treatment options in Philadelphia, PA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Philadelphia research site is actively enrolling participants for this clinical trial. You'll receive care from experienced idiopathic pulmonary fibrosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.